- About Us
- How We Work
- Our Insights
- BSR Conference
- Member Center
May 7, 2014
We sat down with GlaxoSmithKline's Head of Global Corporate Responsibility Clare Griffin to discuss how the healthcare company has evolved its business model.
December 5, 2013
Sustainability professionals can help business promote health and wellness throughout the value chain—via employees, local communities, customers, business partners and suppliers, and the general public.
October 25, 2013
Non-communicable diseases like cancer and diabetes are a growing threat to health and quality of life—but also to healthcare systems and global economies. Recent research by BSR has illuminated how businesses can apply CSR approaches to advance health and wellness across the value chain.
October 15, 2013
Companies are used to looking at supply chain risks related to labor or environmental impacts. But large, distributed supply chains and business networks facilitated by easy air travel are now exposing more people to emerging health risks.
October 11, 2013
Pharmaceutical companies have been working for years to prevent drug shortages, but they still happen. To address discontinuity of supply, pharmaceutical companies should collaborate within their industry and across sectors.
September 24, 2013
As the UN sets about establishing post-2015 development goals, we need new thinking and fresh commitments from across all sectors to develop—and meet—commitments related to global health.
July 11, 2013
To launch our new collaborative initiative, the Guiding Principles on Access to Healthcare, we hosted a webinar with representatives from many sectors in the healthcare industry. Here are three lessons about the principles that can help business tackle major sustainability issues—such as improving global health outcomes.
December 12, 2012
While working nearly a decade for a pharmaceutical think tank, I witnessed how great things can be accomplished when the barriers of competition fall. In my experience, collectively finding solutions not only generates recommendations, guidelines and best practices, it also fosters new models and pushes entire sectors towards faster progress. And today, faster progress is what we need to deliver safer, more affordable, and more effective medicine to larger populations.